<?xml version="1.0" encoding="UTF-8"?>
<p>Cancer that first develops in the liver is called primary liver cancer, and hepatocellular carcinoma (HCC) is the most common one among them. 75%- 85% of primary liver cancers are attributed to HCC, while 10%-15% account for intrahepatic cholangiocarcinoma (ICC), and the residual cases include other rare types [
 <xref rid="pone.0232121.ref001" ref-type="bibr">1</xref>]. The international agency for research on cancer estimated approximately 0.84 million incidences and 0.78 million mortalities worldwide in 2018, which will rise to 1.36 million incidences and 1.28 million deaths by the year 2040. Liver cancer is the sixth most commonly diagnosed cancer, and it was the third cause of mortality worldwide in 2018 among all sexes. Rates of both incidence and mortality are 2 to 3 times higher among men in most of regions worldwide [
 <xref rid="pone.0232121.ref002" ref-type="bibr">2</xref>]. Dynamic temporal trends, marked variations among geographic regions, racial and ethnic groups, and between men and women, and the presence of several well-documented environmental potentially preventable risk factors are several exciting epidemiologic features of HCC [
 <xref rid="pone.0232121.ref003" ref-type="bibr">3</xref>].
</p>
